Newsletter | June 27, 2024

06.27.24 -- B.C.'s Biosimilar Initiative Saves Money, Reinvests To Expand Drug Coverage


AI Integration In Drug Manufacturing: GMP Insights For Operational Excellence, Regulatory Compliance

This article provides insights into a variety of use cases on the application of AI/ML in GMP settings and 5 key considerations for drug manufacturers using AI.

Balanced Sourcing Of Custom Media/Buffer Formulations, Part 2: The Case For Insourcing

In part 1 of this 2-part series, the authors discussed the case for outsourcing of custom media/buffer formulations. In this article, they discuss key considerations in the case for vertical integration or insourcing.

The Growing Demand And Applications For HPLC

High-performance liquid chromatography offers more features compared to other analytical techniques, and the industry is finding more valuable ways to use it.


Meet Submission Timelines With Your Extractables And Leachables Studies

Demonstrating the compatibility of any material in contact with drug product throughout its lifecycle (manufacture, containment, and delivery) is a necessity for a regulatory submission.

Intensification Strategies For Upstream, Downstream Processes

How do you know if an intensification approach will provide advantages? Three process intensification experts show how various intensification approaches affect outputs using different scenarios.


Alvotech And ADVANZ PHARMA Sign Commercialization Agreement For Proposed Biosimilar To Eylea LD/HD In Europe

B.C.'s Biosimilar Initiative Saves Money, Reinvests To Expand Drug Coverage

Samsung Bioepis Presents Post-Hoc Analysis Of Phase 3 Study For EPYSQLI (SB12; Eculizumab Biosimilar), At The European Hematology Association (EHA) Congress 2024


Enabling The Delivery Of Complex Biologics With Ergonomic Solutions